U.S. Household Products Stock News

Albemarle (NYSE:ALB) reported strong first quarter results, with revenue and earnings ahead of analyst expectations. The company completed the sale of its Eurecat joint venture and its controlling stake in Ketjen, receiving substantial net cash proceeds. Albemarle used the proceeds to pay down US$1.3b of debt and reduce interest expenses. The company raised its full year outlook for sales and profitability in its Specialties segment. For investors tracking Albemarle, the latest quarter ties...

Why StoneCo stock is on more watchlists right now StoneCo (STNE) has drawn fresh attention after a month long share price decline of 20.5%, just as the company prepares to report earnings on May 14, 2026. Investors are weighing that recent underperformance against expectations for year over year earnings and revenue growth, trying to decide whether the current price reflects near term risks or potential opportunity. See our latest analysis for StoneCo. Over the past year, StoneCo’s 4.03%...

BridgeBio Pharma recently received Brazilian regulator ANVISA’s approval for BEYONTTRA (acoramidis) to treat adult transthyretin amyloidosis cardiomyopathy (ATTR-CM), based on positive Phase 3 ATTRibute-CM results, and plans to begin commercialization in partnership with Biopas in the second half of 2026. Alongside this new Latin American market entry, BridgeBio is spotlighting its rare disease portfolio with fresh Phase 3 data on acoramidis and encaleret at major global cardiology and...

If you are wondering whether Primerica's recent share price puts the stock on sale or at a premium, the key question is how that price compares with its underlying value. The stock closed at US$276.80, with a 1.1% decline over the last 7 days, a 9.1% gain over 30 days, and returns of 7.0% year to date and 5.5% over the past year. Recent coverage has focused on Primerica's positioning within the insurance sector and how investors are weighing its long term track record against current...

Arrow International issued a nationwide recall of certain dialysis catheter kits that include Merit Medical’s 16F Dual-Valved Splittable Sheath Introducers. The recall is linked to a design defect that may prevent the sheath from splitting as intended during use. The action centers on product quality and regulatory compliance risks that could affect NasdaqGS:MMSI. Merit Medical Systems (NasdaqGS:MMSI) supplies devices used across interventional cardiology, radiology, and vascular access,...

The United States market has seen a robust performance, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to capitalize on undervalued assets.

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking undiscovered gems.

The United States market has experienced a robust performance recently, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, dividend stocks can be an attractive option for investors seeking steady income and potential growth, as they offer regular payouts while benefiting from the overall market's upward momentum.

In late April 2026, MaxLinear announced its Washington 200G/lane TIA for 1.6T optical modules and showcased its Panther V AI storage accelerator platform for data centers, alongside extending its undrawn US$130 million revolving credit facility and reporting first‑quarter 2026 revenue of US$137.19 million with a net loss of US$45.14 million. These AI‑focused product launches, combined with strengthening high‑speed connectivity offerings and additional financial flexibility, highlight...

GigaCloud Technology Inc. has released its first-quarter 2026 results, reporting revenue of US$359.49 million and net income of US$38.12 million, with basic and diluted earnings per share from continuing operations of US$1.04, all higher than the same period last year. The combination of stronger revenue and earnings indicates that GigaCloud’s platform is scaling efficiently, with profitability improving alongside higher transaction volumes rather than being diluted by growth. With...

For investors wondering if Abercrombie & Fitch is still good value after its recent run and subsequent pullbacks, this piece breaks down what the current share price might be implying about the stock. The stock last closed at US$79.40, with returns of 14.0% over the past year. Shorter-term moves include a 5.6% decline over 7 days, an 18.5% decline over 30 days, and a 35.8% decline year to date. Recent price action has put extra attention on whether earlier gains are fully justified or if the...

Q1 performance and capital returns in focus Graham Holdings (GHC) has come onto investors’ radar after reporting Q1 2026 results alongside an update on its ongoing share repurchase, putting both business performance and capital return activity in focus. For the quarter ended March 31, 2026, the company reported revenue of US$1,235.99 million and net income of US$29.11 million. Over the same period, it continued buying back stock, completing the repurchase of 69,708 shares for US$64.89 million...

Earlier this week, Paymentus announced the launch of its patented AI-native Service Commerce platform, including Billeo™ and BillWallet®, which turn bills and statements into intelligent, interactive experiences for understanding, resolving, and paying obligations across multiple channels. At the same time, the company reported first-quarter 2026 results showing higher sales and earnings than a year ago and raised its full-year revenue and contribution profit guidance, underscoring how new...

Investors may be wondering if Newmark Group at around US$16.60 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock has returned 5.3% over the past week and 13.2% over the past month, while the 1 year return sits at 49.7% and the 3 year return is a very large multiple, with a 5 year return of 36.3%. This means recent moves come on top of a sizeable longer term track record. Recent coverage around Newmark Group has focused on its...

International General Insurance Holdings (NasdaqCM:IGIC) opened 2026 with Q1 revenue of US$125.7 million and basic EPS of US$0.49, setting a clear marker for how the year is starting after a solid run of profitability. The company has seen quarterly revenue hover in a tight band between US$125.7 million and US$135.2 million since late 2024, while basic EPS has moved within a range of roughly US$0.49 to US$0.77 over the same stretch, giving investors a consistent read on earnings power. With a...

In late April 2026, CBRE Group reported first-quarter 2026 results showing higher sales and net income than a year earlier, completed a long-running share buyback program totaling US$4.73 billion, and priced a US$750 million senior notes offering mainly to repay commercial paper borrowings. Together, these moves highlight CBRE’s focus on strengthening its balance sheet while returning capital to shareholders, underpinned by growing contributions from infrastructure and outsourcing-related...

Wondering whether Waste Management's current share price reflects its true value, or if you might be paying too much for a steady, essential service stock. The stock recently closed at US$220.52, with returns of a 4.3% decline over 7 days, a 5.7% decline over 30 days, a 1.0% gain year to date, and a 4.9% decline over the past year. The 3 year and 5 year returns stand at 35.4% and 72.5% respectively. Recent coverage has focused on Waste Management's position as a core provider in the...

Pratt & Whitney, part of NYSE:RTX, secured an order to power 150 Airbus A220 aircraft for AirAsia X with its GTF engines, alongside a 12 year maintenance agreement. Raytheon, also under RTX, won its largest contract so far for SharpSight radars, expanding deployment of the surveillance system across multiple international markets. Together, these wins point to growing demand for RTX technologies across both commercial aviation and defense customers. RTX, which last closed at $176.74, is...

Illinois Tool Works (ITW) raised its full year 2026 GAAP EPS guidance to a range of $11.10 to $11.50, alongside Q1 earnings that topped expectations and an outlook for higher operating margins. See our latest analysis for Illinois Tool Works. The raised 2026 guidance and Q1 beat come after a mixed stretch for the stock, with a 2.35% 1 day share price gain but a 9.63% 90 day share price decline, while 1 year total shareholder return of 11.15% points to steadier long term momentum. If you are...

In late April and early May 2026, AbbVie reported first‑quarter revenue of US$15.00 billion alongside a year-on-year drop in net income to US$695 million, while unveiling extensive new clinical and regulatory updates for immunology drugs SKYRIZI and RINVOQ in inflammatory bowel disease, rheumatoid arthritis and alopecia areata. Together with fresh Canadian formulary listings for SKYRIZI in ulcerative colitis and new real‑world data showing lower switch rates and healthcare utilization in...

Why Alaska Air Group Just Tapped the Bond Market Alaska Air Group (ALK) has launched a US$500 million senior unsecured notes offering due 2031, a move that puts its balance sheet decisions and funding mix in clearer focus for stock and bond investors. See our latest analysis for Alaska Air Group. The bond announcement came alongside a short term rebound in the stock, with a 1 day share price return of 5.19% and a 7 day gain of 5.74%. However, the 1 year total shareholder return of 19.24% and...

DoubleVerify Holdings, Inc. recently reported first-quarter 2026 results, posting sales of US$180.83 million and net income of US$6.41 million, with diluted earnings per share from continuing operations of US$0.04, all higher than the same period a year earlier. The combination of higher revenue and improved profitability in the quarter highlights the company’s increasing operational efficiency and ability to convert growth into earnings. We’ll now examine how this improved quarterly...